UNT Health Science Center Researcher Offers Women Hormone Therapy Choice

Printer-friendly version
PR Newswire-US Newswire

FORT WORTH, Texas, May 18, 2011 /PRNewswire-USNewswire/ -- In Texas, 340,000 people suffer with Alzheimer's disease, and that number is expected to grow to 470,000 by 2050.

In the U.S., the number of elderly will increase 102 percent from 2000 to 2030. More than 5 million individuals suffer from Alzheimer's disease, the sixth leading cause of death. The U.S. spends $172 billion annually on Alzheimer's disease, and that is supposed to grow to $1 trillion by 2050.

The cost to our country, including financial, psychological, social and physical costs, is expected to continue growing as the nation's population of elderly increases.

"We need to leave no stone unturned in finding treatments and a cure for Alzheimer's," said Meharvan Singh, Ph.D., chair of the department of Pharmacology and Neurobiology at the UNT Health Science Center at Fort Worth. And hormone treatments may be one of our best bets. "But first, we have to understand how hormones  -- progesterone, testosterone and estrogen – affect bone, heart and brain health, as well as sexual health."

Click here to read more.


BHI Online houses an archive of hormone-related citations for biomedical literature. Also provided are links to PubMed and the NCBI molecular biology resources.


BHI Online strives to support healthcare professionals through webinars presented by leading experts in their respective fields.


Join the conversation with BHI Online's forums aimed at providing information through communities.

Latest News

A selection of stories and articles making headlines in the field of Bioidentical Hormone therapies.

Get In Touch

Locate a BHRT doctor, submit an article or just say hello, we'd love to meet you.

Sub Page: Side Block 1

Sub Page: Side Block 2

Sub Page: Side Block 3

Sub Page: Side Block 4